论文部分内容阅读
据统计，在急性非淋巴细胞白血病（ＡＮＬＬ）发病率中，老年患者占半数以上。ＡＮＬＬ的治疗已成为一个令人关注的问题。我们总结了我院２５例老年ＡＮ－ＬＬ患者在不同剂量ＨＡ（ＶＰ１６），ＤＡ（ＶＰ１６）方案下治疗情况，现报告如下：１ 病例与方法１．１ 病例 １９?
According to statistics, in the incidence of acute non-lymphocytic leukemia (ANLL), older patients account for more than half. The treatment of ANLL has become a concern. We summarized the treatment of 25 cases of elderly patients with AN-LL in our hospital under different doses of HA (VP16) and DA (VP16). The report is as follows: 1 Cases and Methods 1.1 Cases 19?